A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension
Top Cited Papers
Open Access
- 30 April 2006
- journal article
- research article
- Published by Elsevier
- Vol. 151 (4) , 851.e1-851.e5
- https://doi.org/10.1016/j.ahj.2005.09.006
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A comparison of observational studies and controlled trials of heparin in ulcerative colitisInt. Journal of Clinical Pharmacology and Therapeutics, 2004
- Clinical efficacy of sildenafil in primary pulmonary hypertensionJournal of the American College of Cardiology, 2004
- Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial HypertensionCirculation, 2003
- Sildenafil for primary and secondary pulmonary hypertensionClinical Pharmacology & Therapeutics, 2002
- Progress in, and future prospects for, the treatment of primary pulmonary hypertensionHeart, 2001
- Sildenafil Inhibits Hypoxia-Induced Pulmonary HypertensionCirculation, 2001
- Sildenafil in Primary Pulmonary HypertensionNew England Journal of Medicine, 2000
- Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertensionHeart, 2000
- Sildenafil Is a Pulmonary Vasodilator in Awake Lambs with Acute Pulmonary HypertensionAnesthesiology, 2000
- Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats.Journal of Clinical Investigation, 1996